CIK 0001048477 · Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680397820
- Phone
- 4155066700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | FUCHS HENRY J President, Worldwide R&D | Shares withheld for taxes | −33,485 | $83.87 | $2.8M | 196,872 |
| 2024-03-15 | FUCHS HENRY J President, Worldwide R&D | Grant or award · Stock Option (Right to Buy Common Stock) | +40,860 | 40,860 | ||
| 2024-03-15 | Hardy Alexander Chief Executive Officer | Grant or award | +32,780 | 148,151 | ||
| 2024-03-15 | Hardy Alexander Chief Executive Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +44,050 | 44,050 | ||
| 2024-03-15 | BIENAIME JEAN JACQUES Director | Shares withheld for taxes | −85,209 | $83.87 | $7.1M | 474,994 |
| 2024-03-15 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Shares withheld for taxes | −22,580 | $83.87 | $1.9M | 71,467 |
| 2024-03-05 | FUCHS HENRY J President, Worldwide R&D | Sale | −35,341 | $85.18 | $3.0M | 212,117 |
Page 10 of 10 · 187 trades